Pharmacological Dissection of Pupillary Dynamics: μ-Opioid Receptor Miosis and 5−HT2A Receptor Mydriasis as Indices of Divergent Central Arousal States
I. Introduction: The Pupil as a Window to Central Neuromodulation
The Neuroanatomical Substrates of Pupillary Control: Antagonistic Autonomic Dynamics
Pupillary diameter serves as a continuous, non-invasive physiological marker reflecting the dynamic balance of the central nervous system (CNS) autonomic drives.[1] The control of the iris is mediated by two antagonistic branches of the autonomic nervous system (ANS): the parasympathetic system, which causes miosis (pupillary constriction) via the sphincter pupillae muscle, and the sympathetic system, which causes mydriasis (pupillary dilation) via the dilator pupillae muscle.[1]
The parasympathetic pathway for pupillary constriction originates in the Edinger-Westphal preganglionic (EWpg) nucleus, part of the oculomotor nuclear complex in the midbrain.[2] In contrast, the pupillary dilation pathway is a sympathetically driven, three-neuron chain. The first-order neuron begins in the hypothalamus and descends to the ciliospinal center of Budge (C8-T2) in the spinal cord. The second-order neuron ascends to the superior cervical ganglion, and the third-order postganglionic neuron eventually innervates the dilator pupillae.[3] Pharmacological agents targeting the CNS fundamentally disrupt this homeostatic balance, driving the pupil toward either extreme of its functional range. Therefore, the observed pupillary response to psychoactive drugs provides a visible index of which central control system—sympathetic or parasympathetic—has achieved dominance.
The Pupil as a Readout for Central Arousal and Vigilance: The Locus Coeruleus-Norepinephrine Axis
Beyond the light reflex, non-luminance-mediated changes in pupil size are critically regulated by the central neuromodulatory systems associated with arousal and cognitive processing.[4] The Locus Coeruleus-Norepinephrine (LC-NE) system is the primary neural substrate linking pupillary dynamics to cognitive and affective states.[5, 6] The LC, a key arousal nucleus, projects widely throughout the brain, modulating global neural gain.[6]
Pupil size is tightly correlated with LC-NE activity.[7] Fluctuations in pupil diameter are utilized extensively in cognitive neuroscience as a sensitive measure of cognitive load, attention allocation, and mental processing demands.[8, 9] This relationship follows an inverted U-shaped curve, where phasic LC activity is linked to optimal intermediate pupil size, while extreme pupil sizes correspond to deviations in arousal: low tonic LC activity correlates with small pupils (sleepiness or hypo-vigilance), and high tonic LC activity is associated with large pupils (hyper-arousal or high cognitive demand).[7] The strong relationship between LC activity and pupil size makes the pupil a useful, non-invasive indicator for assessing the activity of neuromodulators like Norepinephrine (NE) in the brain.[7]
Given that the sympathetic pathway relies on NE at the neuromuscular junction to facilitate dilation [3], the LC-NE system acts as the unifying framework for analyzing drug-induced pupillary changes. Sympathetic-driven mydriasis is expected to correlate directly with heightened LC-NE activity, reflecting hyper-arousal. Conversely, pharmacological miosis must represent a state where the central sympathetic drive is suppressed, allowing the parasympathetic system to exert central control.
Statement of the Problem and Thesis
Opiates and classic serotonergic psychedelics induce reliable, yet diametrically opposed, pupillary effects: opiates cause miosis (constriction), and psychedelics cause mydriasis (dilation).[10] The objective of this analysis is to dissect the divergent neuropharmacological mechanisms underpinning these antagonistic effects and to synthesize how the resultant pupillary signatures function as biomarkers for profoundly different states of presence and consciousness. The central thesis is that the antagonistic pupillary effects of opioids and psychedelics serve as visible, objective metrics for diametrically opposed CNS states—diminished vigilance due to MOR-mediated parasympathetic dominance, versus an altered state of consciousness sustained by 5−HT2AR-mediated sympathetic hyper-arousal.
II. Opiate-Induced Miosis: Mechanisms of Parasympathetic Dominance and Diminished Vigilance
Molecular Profile of μ-Opioid Receptor (MOR) Activation
Opioid drugs, including exogenous substances such as morphine, heroin, and fentanyl, exert their CNS effects primarily through agonism at the μ-Opioid Receptor (MOR).[11, 12] MORs are G protein-coupled receptors (GPCRs) generally characterized by an inhibitory effect at the neuronal level, leading to presynaptic reduction of neurotransmitter release and postsynaptic hyperpolarization.[13] Among the various opioid receptor subtypes (μ, κ, δ), the μ2 receptor subtype is specifically implicated in mediating several key opioid effects, including analgesia, respiratory depression, euphoria, dependence, and miosis (pupillary constriction).[11] The widespread distribution of MORs across the CNS, including the midbrain and medullary centers, dictates the systemic effects of these drugs.[12]
The Central Mechanism: Paradoxical Disinhibition of EWpg Neurons
The miosis observed following opioid administration is not a peripheral effect but is centrally mediated.[14] It is accomplished by an excitatory action on the pupilloconstrictor neurons located within the visceral nuclei of the oculomotor nuclear complex, commonly referred to as the Edinger-Westphal preganglionic (EWpg) population.[14, 15] Studies have demonstrated that morphine increases the firing frequency of these neurons.[14]
This excitation is considered paradoxical because the MOR itself is inhibitory.[13] The observed physiological result is therefore achieved through central disinhibition.[15, 16] This mechanism postulates that μ-opioid agonists inhibit an intervening inhibitory neuron that normally regulates the EWpg nucleus.[14, 16] By removing this inhibitory input—a “release of the brake”—the EWpg neurons become tonically active, leading to sustained parasympathetic overactivity and resulting in miosis.[16] It is critical to differentiate the cholinergic EWpg neurons (responsible for constriction) from the centrally projecting peptidergic neurons (EWcp), confirming that opioids selectively drive the constrictor pathway.[2] This centrally mediated constriction overrides the baseline sympathetic tone, enforcing parasympathetic dominance and stabilizing the pupil at a small diameter, typically 2 to 3 mm.[17]
Miosis as a Predictor of Central Nervous System Depression
The pharmacological imposition of miosis reflects a global reduction in central arousal and vigilance. Opioid-induced miosis correlates reliably with systemic effects such as drug plasma concentration and general CNS depression.[12, 18]
The anatomical and functional connection between the central mechanism of miosis and life-threatening toxicity is well-established. The pupilloconstrictor neurons of the oculomotor nuclear complex are located in close proximity to the medullary respiratory centers, both of which are densely populated with MORs.[15] Consequently, the same μ-opioid agonism that drives miosis is responsible for respiratory depression (RD).[15] Since low LC activity is strongly associated with sleepiness and small pupils [7], the profound miosis induced by opioids serves as a macroscopic, objective biomarker for this pharmacologically-imposed state of low arousal and diminishing vigilance.
In clinical settings, quantitative pupillometry (QP) is increasingly used as an objective, non-invasive tool to monitor this state of systemic suppression.[15] Pupil diameters remain tightly constricted (2–3 mm) even under conditions of maximal hypoxia and hypercarbia accompanying opioid toxicity.[17] Measures such as pupillary unrest in ambient light (PUAL) have been investigated as predictors for severe respiratory depression.[19] QP has demonstrated small but significant changes in mean pupil size within 15 minutes of opioid agonist therapy (OAT) dosing, correlating with lower clinical opiate withdrawal scores and providing real-time data on central neurological status that transcends subjective assessment.[20, 21]
III. Psychedelic-Induced Mydriasis: Mechanisms of Sympathetic Overdrive and Hyper-Arousal
Molecular Target: 5−HT2A Receptor Agonism
In direct contrast to the inhibitory mechanism of opioids, the physiological and psychoactive effects of classic serotonergic psychedelics (e.g., LSD, psilocybin/psilocin, DMT) are primarily mediated by agonism at the Serotonin 5−HT2A receptor (5−HT2AR).[22, 23, 24] The 5−HT2AR is a G protein-coupled receptor that predominantly couples with Gαq downstream effector systems.[22] This coupling leads to increased neuronal excitability, particularly in high-level associative cortices such as the medial prefrontal cortex (mPFC), a region rich in 5−HT2AR expression.[22]
Central Activation of the Oculosympathetic Pathway
The mydriasis characteristic of the psychedelic state is a direct consequence of massive central activation of the oculosympathetic pathway.[10] Research using selective 5−HT2 agonists, such as DOI, has demonstrated a potent, dose-dependent increase in spontaneous sympathetic nerve discharge (SSND).[25] This sympathetic activation can be extreme, documented to reach 1750% of control values, an effect that is completely reversible by 5−HT2 antagonists.[25]
Since pupillary dilation is exclusively driven by sympathetic activation, which originates centrally in the hypothalamus and drives the dilator pupillae muscle [1, 3], the surge in sympathetic nerve discharge translates directly into sustained mydriasis.[10] The underlying mechanism is thus a massive excitatory signal that overwhelms the baseline autonomic control, compelling the sympathetic system into a state of hyper-dominance. This robust excitatory drive is fundamentally different from the disinhibitory mechanism observed with opiates, representing a direct pharmacological push toward maximum sympathetic outflow.
Mydriasis as an Index of Central Excitability and Hyper-Modulation
The resulting mydriasis is an inescapable physiological manifestation of the acute hyper-arousal state induced by 5−HT2AR agonism. The 5−HT2AR-mediated excitation in cortical regions [24] provides the physiological substrate for the radical alterations in consciousness. The dilated pupil signifies high tonic LC activity [7], which provides the necessary neuromodulatory resources (neural gain) required to reorganize functional brain connectivity.
Neuroimaging studies of psychedelics, such as DMT and psilocybin, consistently reveal a state of profound altered consciousness characterized by robust increases in global functional connectivity (GFC), reduced modularity, and increased signal entropy.[26, 27, 28] Importantly, DMT induces this altered experience without any corresponding diminishment of wakefulness, confirming a state of hyper-arousal and increased processing complexity.[26] The sustained mydriasis serves as an objective, visible indicator of this underlying high-gain neural state that supports “unconstrained cognition” and facilitates the subjective effects, such as mystical experiences and boundary dissolution.[28, 29]
IV. Differential Autonomic Signatures and Neural Correlates of Consciousness
The opposing effects of opiates and psychedelics on pupillary diameter provide an essential neurophysiological tool for distinguishing two fundamental ways psychoactive substances interact with consciousness: suppressing the level of consciousness (vigilance) versus altering the content of consciousness (subjective experience).
The LC-NE System: Integrating Pupillary Response with Arousal States
The LC-NE system provides the mechanistic foundation for integrating these pharmacological effects. As pupil diameter directly indexes LC activity [7], it becomes possible to correlate the antagonistic drug actions with distinct ranges of the arousal spectrum.
Opioids, through global CNS suppression, drive the system to low tonic LC activity, correlating with small pupils, hypo-vigilance, and depressed physiological function.[7, 15] Conversely, psychedelics, through massive 5−HT2AR-mediated sympathetic excitation, drive the system to high tonic LC activity, correlating with large pupils and the necessary neural gain to support high-complexity, disorganized cortical processing.[7, 26] This unified perspective, supported by the correlation between pupil dilation and BOLD activity in the LC and cortical attention networks, validates the pupillary response as a sensitive marker for the state of central neuromodulation.[30]
Opioid Signature: Miosis and Diminished Level of Consciousness
The opioid-induced miosis is a hallmark of diminished level of consciousness. The mechanism is rooted in centralized parasympathetic control overwhelming suppressed sympathetic outflow, producing a state of sedation.[12] The resulting constricted pupils (2–3 mm) indicate pharmacological suppression of the central arousal state.[17] The clinical significance is profound: miosis serves as a physiological measure of the systemic neurological risk associated with CNS depression and the associated life-threatening respiratory depression.[15] This pupillary signature acts as an indicator that the organism’s critical homeostatic regulatory processes are being functionally compromised, consistent with findings that the risk of death rises significantly with increasing doses and co-administration of sedatives.[31]
Psychedelic Signature: Mydriasis and Altered Content of Consciousness
Psychedelic mydriasis, representing a state of high central arousal, reflects a qualitative shift in the content of consciousness without the loss of wakefulness.[26] The massive sympathetic drive manifested by mydriasis provides the necessary energetic capacity (high neural gain) for the brain to achieve a state characterized by widespread functional hyperconnectivity and decreased segregation between network components.[26, 27] The maintenance of high arousal, reflected in the large pupil size [7], is essential for supporting the complex, novel subjective experiences associated with psychedelics, such as mystical experiences, which involve substantial reorganization of internal and external information processing.[28, 29] Mydriasis is therefore the autonomic corollary of the hyper-modulated brain state.
The synthesis of these relationships emphasizes that the diametric pupillary responses provide an objective metric for distinguishing two fundamental outcomes of pharmacological action: systemic neurological suppression versus functional neural reorganization.
Table 2: Pupillary Signatures and Correlates of Consciousness: The LC-NE Axis
| Pharmacological/Cognitive State | Pupil Diameter | LC-NE Activity Level | Neural Correlate of Consciousness |
| Opioid Use/Sedation | Small (Miosis) | Low Tonic Activity [7] | Suppression of Vigilance, Risk of CNS Depression/RD [15] |
| Optimal Attention/Cognitive Load | Medium | Phasic Activity [7, 9] | High Cognitive Gain, Efficient Information Processing [30] |
| Psychedelic Use/ASC | Large (Mydriasis) | High Tonic Activity / Hyper-arousal [7, 25] | Global Hyperconnectivity, Increased Entropy, Altered Content of Consciousness [26, 27] |
V. Discussion and Conclusion
Synthesis of Opposing Central Pharmacological Effects
The analysis demonstrates that the pupil serves as a highly sensitive integrator of neuropharmacological signaling. Opiates achieve miosis via a central disinhibition mechanism targeting the EWpg nucleus through inhibitory MORs, effectively allowing parasympathetic tone to dominate. This action is closely linked to the respiratory and sedative effects characteristic of μ-agonism. Conversely, psychedelics achieve mydriasis via direct, massive 5−HT2AR-mediated excitation, resulting in extreme sympathetic nerve discharge and hyper-arousal. The resulting pupillary responses—constriction in one case and dilation in the other—are therefore not coincidental side effects, but rather accurate macroscopic representations of diametrically opposite central nervous system states of vigilance and neuromodulatory tone.
Clinical and Research Significance of Pupillometry as a Non-Invasive Biomarker
The established neurobiological links reinforce the utility of pupillometry as a powerful, non-invasive biomarker for evaluating central status across varied clinical and research environments.
In the clinical context of opioid management, quantitative pupillometry (QP) offers a critical tool for moving beyond subjective sedation scales.[20] By providing objective, real-time measures of pupil size and reactivity, QP allows clinicians to continuously monitor the systemic CNS depression induced by opioids, aiding in the proactive identification of patients at risk for respiratory depression in post-anesthesia recovery units and intensive care settings.[15, 19]
In psychedelic research, pupillometry quantifies the physiological component of the altered state of consciousness. The maintenance of mydriasis during the acute drug phase serves as a measurable index of the hyper-arousal and increased neural gain supporting the profound cortical reorganization (hyperconnectivity and entropy).[26] Correlating this physiological arousal with subjective reports (e.g., boundary dissolution) can provide deeper insights into the neurobiological basis of the therapeutic potential of psychedelics.[28]
Future Directions in Multimodal Neuromodulation Research
To fully elucidate the mechanistic differences detailed herein, future studies must integrate QP with high temporal resolution neuroimaging modalities (e.g., simultaneous fMRI-EEG) during the acute administration of both MOR and 5−HT2AR agonists. Such studies should focus on establishing direct functional connectivity changes between the key antagonistic control centers—the EWpg and the LC-NE system—and correlate these changes with instantaneous pupillary dynamics. This unified, multimodal approach is necessary to definitively map molecular action onto circuit-level dynamics and global states of consciousness, refining the pupil’s role as a robust and objective biomarker for assessing central neuromodulation.
——————————————————————————–
1. Neuromodulatory Correlates of Pupil Dilation – Frontiers, https://www.frontiersin.org/journals/neural-circuits/articles/10.3389/fncir.2018.00021/full
2. THE EDINGER-WESTPHAL NUCLEUS: A HISTORICAL, STRUCTURAL AND FUNCTIONAL PERSPECTIVE ON A DICHOTOMOUS TERMINOLOGY – PubMed Central, https://pmc.ncbi.nlm.nih.gov/articles/PMC3675228/
3. Neuroanatomy, Pupillary Dilation Pathway – StatPearls – NCBI Bookshelf – NIH, https://www.ncbi.nlm.nih.gov/books/NBK535421/
4. Oculometric signature of switch into awareness? Pupil size predicts sudden insight whereas microsaccades predict problem-solving via analysis – PMC – PubMed Central, https://pmc.ncbi.nlm.nih.gov/articles/PMC7440842/
5. The Locus Coeruleus- Norepinephrine System in Stress and Arousal: Unraveling Historical, Current, and Future Perspectives – Frontiers, https://www.frontiersin.org/journals/psychiatry/articles/10.3389/fpsyt.2020.601519/full
6. Pupil-linked arousal, cortical activity, and cognition in Alzheimer’s disease | Brain Communications | Oxford Academic, https://academic.oup.com/braincomms/article/7/4/fcaf236/8210142
7. From pupil to the brain: New insights for studying cortical plasticity through pupillometry – PMC – PubMed Central, https://pmc.ncbi.nlm.nih.gov/articles/PMC10102476/
8. Pupil dilation as an index of effort in cognitive control tasks: A review – PubMed Central, https://pmc.ncbi.nlm.nih.gov/articles/PMC6267528/
9. Pupillometry as a Measure of Cognitive Effort in Younger and Older Adults – PubMed Central, https://pmc.ncbi.nlm.nih.gov/articles/PMC2867103/
10. Illicit drugs: Effects on eye – PMC – PubMed Central, https://pmc.ncbi.nlm.nih.gov/articles/PMC6886135/
11. Physiology, Opioid Receptor – StatPearls – NCBI Bookshelf, https://www.ncbi.nlm.nih.gov/books/NBK546642/
12. Intrathecal Morphine – StatPearls – NCBI Bookshelf – NIH, https://www.ncbi.nlm.nih.gov/books/NBK499880/
13. Opioid Receptor-Mediated Regulation of Neurotransmission in the Brain – Frontiers, https://www.frontiersin.org/journals/molecular-neuroscience/articles/10.3389/fnmol.2022.919773/full
14. Mechanism of morphine-induced miosis in the dog – PubMed, https://pubmed.ncbi.nlm.nih.gov/1117427/
15. Quantitative pupillometry as a predictor of pediatric postoperative opioid induced respiratory depression – IU Indianapolis ScholarWorks, https://scholarworks.indianapolis.iu.edu/bitstreams/3937dd33-096d-42eb-91f7-b69f1772685d/download
16. Mechanism of opioid-induced pupillary effects | Request PDF – ResearchGate, https://www.researchgate.net/publication/5454576_Mechanism_of_opioid-induced_pupillary_effects
17. Pupillary effects of high-dose opioid quantified with infrared pupillometry – PubMed, https://pubmed.ncbi.nlm.nih.gov/25068603/
18. pi :: Psychiatry Investigation, https://www.psychiatryinvestigation.org/m/journal/view.php?number=1243
19. Opioid Effect and Acute Pain (Chapter 12) – A Practical Guide to Portable Pupillometry, https://www.cambridge.org/core/books/practical-guide-to-portable-pupillometry/opioid-effect-and-acute-pain/F3FA93EEF18D6327B00F0E844E374A5C
20. A Pilot Study of Automated Pupillometry in the Treatment of Opioid Use Disorder – NIH, https://pmc.ncbi.nlm.nih.gov/articles/PMC8562941/
21. Looking at the Eye’s Pupil Size for Effective Opioid Agonist Therapy – HealthCity, https://healthcity.bmc.org/looking-pupil-size-effective-opioid-agonist-therapy/
22. Psychedelic compounds directly excite 5-HT2A layer V medial prefrontal cortex neurons through 5-HT2A Gq activation – PubMed Central, https://pmc.ncbi.nlm.nih.gov/articles/PMC12501219/
23. Psilocybin – Wikipedia, https://en.wikipedia.org/wiki/Psilocybin
24. The role of serotonin 5-HT2A receptors in memory and cognition – Frontiers, https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2015.00225/full
25. 5-HT2 receptor agonists increase spontaneous sympathetic nerve …, https://pubmed.ncbi.nlm.nih.gov/3416918/
26. Human brain effects of DMT assessed via EEG-fMRI – PNAS, https://www.pnas.org/doi/10.1073/pnas.2218949120
27. Meditation, Psychedelics, and Brain Connectivity: A Randomised Controlled Resting-State fMRI Study of N,N-Dimethyltryptamine and Harmine in a Meditation Retreat | medRxiv, https://www.medrxiv.org/content/10.1101/2025.07.30.25332422v1.full-text
28. Alterations in brain network connectivity and subjective experience induced by psychedelics: a scoping review – PubMed Central, https://pmc.ncbi.nlm.nih.gov/articles/PMC11131165/
29. Psychedelics Align Brain Activity with Context – bioRxiv, https://www.biorxiv.org/content/biorxiv/early/2025/06/22/2025.03.09.642197.full.pdf
30. Pupil size signals mental effort deployed during multiple object tracking and predicts brain activity in the dorsal attention network and the locus coeruleus – Journal of Vision, https://jov.arvojournals.org/article.aspx?articleid=2121393
31. Mixing Opioids and Sedatives Steeply Raises Overdose Risk – DEOHS, https://deohs.washington.edu/news/mixing-opioids-and-sedatives-steeply-raises-overdose-risk
